184 related articles for article (PubMed ID: 17309824)
1. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
Kato K; Chu P; Takahashi S; Hamada H; Kipps TJ
Exp Hematol; 2007 Mar; 35(3):434-42. PubMed ID: 17309824
[TBL] [Abstract][Full Text] [Related]
2. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P
Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD27 induces IgG production through activation of antigen-primed B cells.
Dang LV; Nilsson A; Ingelman-Sundberg H; Cagigi A; Gelinck LB; Titanji K; De Milito A; Grutzmeier S; Hedlund J; Kroon FP; Chiodi F
J Intern Med; 2012 Mar; 271(3):282-93. PubMed ID: 21917027
[TBL] [Abstract][Full Text] [Related]
4. Control of lymphocyte function through CD27-CD70 interactions.
Lens SM; Tesselaar K; van Oers MH; van Lier RA
Semin Immunol; 1998 Dec; 10(6):491-9. PubMed ID: 9826582
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
7. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL.
Nilsson A; de Milito A; Mowafi F; Winberg G; Björk O; Wolpert EZ; Chiodi F
Exp Hematol; 2005 Dec; 33(12):1500-7. PubMed ID: 16338493
[TBL] [Abstract][Full Text] [Related]
10. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response.
Orsini E; Guarini A; Chiaretti S; Mauro FR; Foa R
Cancer Res; 2003 Aug; 63(15):4497-506. PubMed ID: 12907623
[TBL] [Abstract][Full Text] [Related]
11. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
Spaner DE; Hammond C; Mena J; Shi Y
Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
[TBL] [Abstract][Full Text] [Related]
12. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27.
Agematsu K; Kobata T; Sugita K; Freeman GJ; Beckmann MP; Schlossman SF; Morimoto C
J Immunol; 1994 Aug; 153(4):1421-9. PubMed ID: 8046222
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
[TBL] [Abstract][Full Text] [Related]
14. CD27/CD70 interaction contributes to the activation and the function of human autoreactive CD27+ regulatory T cells.
Jacquot S; Kobata T; Iwata S; Schlossman SF; Morimoto C
Cell Immunol; 1997 Jul; 179(1):48-54. PubMed ID: 9259771
[TBL] [Abstract][Full Text] [Related]
15. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
Wischhusen J; Jung G; Radovanovic I; Beier C; Steinbach JP; Rimner A; Huang H; Schulz JB; Ohgaki H; Aguzzi A; Rammensee HG; Weller M
Cancer Res; 2002 May; 62(9):2592-9. PubMed ID: 11980654
[TBL] [Abstract][Full Text] [Related]
16. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.
Oelke K; Lu Q; Richardson D; Wu A; Deng C; Hanash S; Richardson B
Arthritis Rheum; 2004 Jun; 50(6):1850-60. PubMed ID: 15188362
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
Ranheim EA; Cantwell MJ; Kipps TJ
Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
[TBL] [Abstract][Full Text] [Related]
19. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.
McWhirter JR; Kretz-Rommel A; Saven A; Maruyama T; Potter KN; Mockridge CI; Ravey EP; Qin F; Bowdish KS
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1041-6. PubMed ID: 16418292
[TBL] [Abstract][Full Text] [Related]
20. The role and expression of CD27 and CD70 lymphocytes in the human tonsil.
Yokoi H; Seki M; Okazoe S; Okumura K; Yoshikawa H
Lymphology; 2003 Jun; 36(2):74-83. PubMed ID: 12926832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
